Several years ago, I was contracted to perform an evaluation study for an existing biosafety level-3 (BSL-3) biocontainment laboratory on the West Coast. The lab was actively performing research on ...
When the COVID-19 pandemic arrived in the United States in 2020, the American research community experienced a sudden spike in funding. Universities, pharmaceutical companies, and state and federal ...
The MarketWatch News Department was not involved in the creation of this content. Many modern medicines rely on biologic and genetic materials, such as proteins, viral vectors, and DNA/mRNA, rather ...
BSL-2 is designed for work with agents that pose moderate hazards to personnel and the environment. These agents are associated with human diseases that are generally treatable or preventable. Agents ...
Not long after SARS-CoV-2 was first identified in December 2019 as the cause of an alarming cluster of severe pneumonia cases in central China, the U.S. Centers for Disease Control and Prevention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback